English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 18 Help

Selected(0)Clear Items/Page:    Sort:
Real-World Utilization and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Dosed Weekly and Daily in Patients with Type 2 Diabetes Mellitus: Results from Retrospective Electronic Medical Records in China Journal article
Ruan, Zhen, Chen, Xianwen, Song, Menghuan, Jia, Ruxu, Luo, Hang, Ung, Carolina Oi Lam, Hu, Hao. Real-World Utilization and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Dosed Weekly and Daily in Patients with Type 2 Diabetes Mellitus: Results from Retrospective Electronic Medical Records in China[J]. Diabetes, Metabolic Syndrome and Obesity, 2024, 17, 3657-3666.
Authors:  Ruan, Zhen;  Chen, Xianwen;  Song, Menghuan;  Jia, Ruxu;  Luo, Hang; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.8/3.3 | Submit date：2024/11/05
Type 2 Diabetes Mellitus  Glucagon-like Peptide-1 Receptor Agonist  Glp-1ra  Retrospective  China  Electronic Medical Record  Real-world  
Supercharged precision killers: Genetically engineered biomimetic drugs of screened metalloantibiotics against Acinetobacter baumanni Journal article
Wei, Xianyuan, Xue, Bin, Ruan, Shuangchen, Guo, Jintong, Huang, Yujing, Geng, Xiaorui, Wang, Dan, Zhou, Cangtao, Zheng, Jun, Yuan, Zhen. Supercharged precision killers: Genetically engineered biomimetic drugs of screened metalloantibiotics against Acinetobacter baumanni[J]. Science Advances, 2024, 10(12), eadk6331.
Authors:  Wei, Xianyuan;  Xue, Bin;  Ruan, Shuangchen;  Guo, Jintong;  Huang, Yujing; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:11.7/13.7 | Submit date：2024/05/16
Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature Journal article
Xue, Yan, Zou, Huimin, Ruan, Zhen, Chen, Xianwen, Lai, Yunfeng, Yao, Dongning, Ung, Carolina Oi Lam, Hu, Hao. Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature[J]. Frontiers in Endocrinology, 2023, 14, 1254398.
Authors:  Xue, Yan;  Zou, Huimin;  Ruan, Zhen;  Chen, Xianwen;  Lai, Yunfeng; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:3.9/4.9 | Submit date：2024/02/22
Anti-obesity Drugs  Cost-effectiveness  Methodology  Modeling  Obesity  
Policy analysis of system responses to addressing and reversing the obesity trend in China: a documentary research Journal article
Yan Xue, Zhen Ruan, Carolina Oi Lam Ung, Yunfeng Lai, Hao Hu. Policy analysis of system responses to addressing and reversing the obesity trend in China: a documentary research[J]. BMC Public Health, 2023, 23(1), 1198.
Authors:  Yan Xue;  Zhen Ruan;  Carolina Oi Lam Ung;  Yunfeng Lai;  Hao Hu
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:3.5/3.9 | Submit date：2023/08/03
China  Health Policy  Health System  Obesity  
Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review Journal article
Zhen Ruan, Yixuan Jiang, Honghao Shi, Ruxu Jia, Carolina Oi Lam Ung, Hao Hu. Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review[J]. Expert Review of Clinical Pharmacology, 2023, 16(2), 161-176.
Authors:  Zhen Ruan;  Yixuan Jiang;  Honghao Shi;  Ruxu Jia;  Carolina Oi Lam Ung; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:3.6/4.1 | Submit date：2023/08/03
Effectiveness  Glp-1ra  Hba1c  O.w. Semaglutide  Type 2 Diabetes  Real-world Evidence  Review  Weight  
Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China Journal article
Liu, Lei, Ruan, Zhen, Ung, Carolina Oi Lam, Zhang, Yawen, Shen, Yang, Han, Sheng, Jia, Ruxu, Qiao, Jingtao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China[J]. Diabetes Therapy, 2023, 14(1), 93-107.
Authors:  Liu, Lei;  Ruan, Zhen;  Ung, Carolina Oi Lam;  Zhang, Yawen;  Shen, Yang; et al.
Favorite | TC[WOS]:6 TC[Scopus]:8  IF:2.8/2.9 | Submit date：2023/01/08
Cost-effectiveness Analysis  Type 2 Diabetes  Glucagon-like Peptide-1 Analogue  Semaglutide  Peg-loxenatide  China  
Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials Journal article
Lin, Qiucen, Xue, Yan, Zou, Huimin, Ruan, Zhen, Ung, Carolina Oi Lam, Hu, Hao. Efficacy and safety of liraglutide for obesity and people who are overweight: a systematic review and meta-analysis of randomized controlled trials[J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15(12), 1461-1469.
Authors:  Lin, Qiucen;  Xue, Yan;  Zou, Huimin;  Ruan, Zhen;  Ung, Carolina Oi Lam; et al.
Favorite | TC[WOS]:9 TC[Scopus]:8  IF:3.6/4.1 | Submit date：2023/01/08
Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China Journal article
Ruan, Zhen, Ung, Carolina Oi Lam, Shen, Yang, Zhang, Yawen, Wang, Weihao, Luo, Jingyi, Zou, Huimin, Xue, Yan, Wang, Yao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China[J]. DIABETES THERAPY, 2022, 13(10), 1737-1753.
Authors:  Ruan, Zhen;  Ung, Carolina Oi Lam;  Shen, Yang;  Zhang, Yawen;  Wang, Weihao; et al.
Favorite | TC[WOS]:5 TC[Scopus]:8  IF:2.8/2.9 | Submit date：2022/08/28
China  Cost-effectiveness  Diabetes  Dulaglutide  Semaglutide  
CEA OF ONCE-WEEKLY SUBCUTANEOUS SEMAGLUTIDE VERSUS DULAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES WITH INADEQUATE GLYCEMIC CONTROL IN CHINA Conference proceedings
Authors:  Ruan, Zhen;  Ung, Oi Lam Carolina;  Shen, Y;  Zou, H;  Xue, Y; et al.
Favorite |  | Submit date：2022/08/28
Pharmacoeconomic evaluation of dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus: a systematic literature review Review article
2022
Authors:  Ruan, Zhen;  Zou, Huimin;  Lei, Qing;  Ung, Carolina Oi Lam;  Shi, Honghao; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:1.8/2.2 | Submit date：2022/05/17
Cost-effectiveness  Dipeptidyl Peptidase-4 Inhibitors  Dpp-4i  Pharmacoeconomic  Systematic Review  Type 2 Diabetes Mellitus